Literature DB >> 6933547

Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma').

C Wolfenstein-Todel, M W Mosesson.   

Abstract

Two types of normal human plasma fibrinogen--peak 1 and peak 2--are distinquishable by DEAE-cellulose gradient elution chromatography. The elution characteristics of peak 2 fibrinogen, which amounts to about 15% of the total, are attributable to the presence of a gamma chain variant, gamma', which is more negatively charged than gamma chains and makes up about half of all such chains in that peak [Mosesson M. W., Finlayson, J. S. & Umfleet, R. A. (1972), J. Biol. Chem. 247, 5223-5227]. Analyses of reduced S-carboxymethylated fibrin that had first been incubated in the presence of Factor XIIIa plus the fluorescent amine donor dansylcadaverine (DNScad) showed that the same amount of this compound could be incorporated covalently into either type of gamma chain. Furthermore, the DNScad-labeled COOH-terminal CNBr fragment (CNBr e) derived from the S-carboxymethylated gamma chain was smaller than the DNScad-labeled fragment (CNBr e') from the gamma' chain (Mr, 3200 and 4900) by about the same amount as the difference in size between the respective parent chains (Mr, 49,400 and 51,500). DNScad-CNBr e or DNScad-cNBR e' could be further cleaved by trypsin to yield a smaller fluorescent fragment corresponding to the penultimate tryptic gamma chain peptide containing the DNScad-glutamine acceptor and lysine donor crosslinking functions. The COOH-terminal amino acids of gamma and gamma' chains were valine and leucine, respectively. The rates of Factor XIIIa-catalyzed crosslinking of peak 1 and peak 2 fibrin were the same, but peak 1 fibrin gamma chains formed only one species of crosslinked dimer (gamma gamma) whereas peak 2 fibrin gamma chains yielded three (gamma gamma, gamma gamma', gamma'gamma'). We conclude that gamma' chains are functionally normal but have an extended COOH-terminal sequence accounting for their more negative charge and larger size relative to gamma chains.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933547      PMCID: PMC349997          DOI: 10.1073/pnas.77.9.5069

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Peptide separation by two-dimensional chromatography and electrophoresis.

Authors:  A M KATZ; W J DREYER; C B ANFINSEN
Journal:  J Biol Chem       Date:  1959-11       Impact factor: 5.157

2.  Studies on the structural abnormality of fibrinogen Paris I.

Authors:  M W Mosesson; D L Amrani; D Ménaché
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

3.  Sequence analysis of porcine gut GLI-1.

Authors:  H Jacobsen; A Demandt; A J Moody; F Sundby
Journal:  Biochim Biophys Acta       Date:  1977-08-23

4.  The readthrough protein A1 is essential for the formation of viable Q beta particles.

Authors:  H Hofstetter; H J Monstein; C Weissmann
Journal:  Biochim Biophys Acta       Date:  1974-12-06

5.  Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.

Authors:  M W Mosesson; J S Finlayson; R A Umfleet; D Galanakis
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

6.  Titration of the acceptor cross-linking sites in fibrin.

Authors:  L Lorand; D Chenoweth; A Gray
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

7.  - cross-linking sites in human and bovine fibrin.

Authors:  R Chen; R F Doolittle
Journal:  Biochemistry       Date:  1971-11-23       Impact factor: 3.162

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  A UGA termination suppression tRNATrp active in rabbit reticulocytes.

Authors:  A I Geller; A Rich
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Human fibrinogen heterogeneities. Preparation and characterization of gamma and gamma' chains.

Authors:  N E Stathakis; M W Mosesson; D K Galanakis; D Ménaché
Journal:  Thromb Res       Date:  1978-09       Impact factor: 3.944

View more
  22 in total

1.  Platelet alpha-granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes.

Authors:  P Handagama; D A Rappolee; Z Werb; J Levin; D F Bainton
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin.

Authors:  M W Mosesson; K R Siebenlist; D L Amrani; J P DiOrio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

4.  Carboxyl-terminal amino acid sequences of two variant forms of the gamma chain of human plasma fibrinogen.

Authors:  C W Francis; E Müller; A Henschen; P J Simpson; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology.

Authors:  E A Ryan; L F Mockros; A M Stern; L Lorand
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

6.  Xenopus fibrinogen: characterization of the mRNAs for the three subunits.

Authors:  L J Holland; L J Wangh
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

7.  Fibrinogen gamma chain locus is on chromosome 4 in man.

Authors:  B Olaisen; P Teisberg; T Gedde-Dahl
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

8.  Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

9.  The presence of gamma' chain impairs fibrin polymerization.

Authors:  Kathryn C Gersh; Chandrasekaran Nagaswami; John W Weisel; Susan T Lord
Journal:  Thromb Res       Date:  2009-01-12       Impact factor: 3.944

10.  Role of fibrinogen alpha and gamma chain sites in platelet aggregation.

Authors:  D H Farrell; P Thiagarajan; D W Chung; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.